Exogenous Oxytocin Administration Restores Memory in Female APP/PS1 Mice
Journal of Alzheimer’s Disease · 2023
DOI: 10.3233/jad-230657 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Alzheimer’s Disease, 2023. Verfasst von Philippos Koulousakis und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University, Maastricht, The Netherlands. Hauptthemen laut MEDLINE: Alzheimer Disease, Amyloid beta-Peptides, Oxytocin, Presenilin-1. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Current treatment options for Alzheimer’s disease (AD) are limited, inefficient, and often have serious side effects. Oxytocin is a neuropeptide implicated in a variety of central processes, such as social and reproductive behaviors. Among others, it has garnered attention in various domains of psychiatric research, while its role in the development and course of neurodegenerative disorders like AD is rather unknown.
Objective
This study aimed to investigate the role of exogenous oxytocin administration on memory, specifically in view of AD, as a potential novel treatment option.
Methods
We describe a novel treatment approach by using a relatively low dose of long-term intranasal oxytocin treatment, to restore memory deficits in female APPswePS1dE9 mice.
Results
Female APPswePS1dE9 mice treated with oxytocin showed increased spatial memory performance in the object location task and improved working memory in the Y-Maze, while indicating decreased sociability.
Conclusions
These results indicate that oxytocin is able to reverse acquired cognitive deficits in female APPswePS1dE9 mice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University, Maastricht, The Netherlands.
- Department of Neuroscience, Biomedical Research Institute, Faculty of Medicine and Life Sciences, Hasselt University, Hasselt, Belgium.
Zitieren
APA
Koulousakis, P., Willems, E., Schepers, M., Rombaut, B., Prickaerts, J., Vanmierlo, T., & van den Hove, D. (2023). Exogenous Oxytocin Administration Restores Memory in Female APP/PS1 Mice. Journal of Alzheimer’s Disease. https://doi.org/10.3233/jad-230657
Vancouver
Koulousakis P, Willems E, Schepers M, Rombaut B, Prickaerts J, Vanmierlo T, et al. Exogenous Oxytocin Administration Restores Memory in Female APP/PS1 Mice. Journal of Alzheimer’s Disease. 2023. doi:10.3233/jad-230657
BibTeX
@article{Koulousakis2023,
author = {Koulousakis, Philippos and Willems, Emily and Schepers, Melissa and Rombaut, Ben and Prickaerts, Jos and Vanmierlo, Tim and van den Hove, Daniel},
title = {Exogenous Oxytocin Administration Restores Memory in Female APP/PS1 Mice},
journal = {Journal of Alzheimer’s Disease},
year = {2023},
doi = {10.3233/jad-230657}
}
EUVIMED